Cancer survival in Africa, Asia, the Caribbean and Central America (SurvCan)

You are here: Home / Statistics / Comparative statistics by registry

Comparative statistics by cancer registry

Table3: Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site

(Mumbai, India, 1992-1994 cases followed through 1999 and 1995-1999 cases followed-up until 2003)

Click on cancer site (ICD-10 code) for comparison

Site	ICD-10	Total	Absolute survival %			Relative survival %			ASRS% at 5-years
Site	ICD-10	Total	1-year	3-year	5-year	1-year	3-year	5-year	all ages	0-74 years
C00	Lip	161	78.8	62.7	55.8	80.9	67.7	63.6	63.4	61.3
C01-02	Tongue	2106	56.5	31.2	25.3	58.3	34.2	29.3	27.8	29.7
C03-06	Oral cavity	2769	60.5	39.4	32.3	62.2	42.8	37.0	35.0	36.0
C09	Tonsil	513	46.7	20.3	13.9	48.4	22.6	16.7	16.7	16.6
C10	Other oropharynx	243	51.5	23.6	15.7	53.3	26.2	18.6	18.3	20.4
C11	Nasopharynx	243	57.3	28.7	22.9	58.6	30.8	25.5	20.3	24.7
C12-13	Hypopharynx	1902	47.5	23.3	17.8	49.3	26.3	21.7	21.8	23.1
C15	Oesophagus	3128	36.8	18.9	13.0	38.3	21.1	15.4	13.7	16.2
C16	Stomach	2205	33.6	17.6	12.8	34.8	19.5	14.8	11.6	15.2
C18	Colon	1578	52.5	35.1	27.4	54.5	38.8	32.3	25.4	30.3
C19-20	Rectum	1217	59.7	37.2	28.6	61.9	41.2	33.6	26.1	31.1
C21	Anus	220	62.8	42.3	34.0	64.8	46.3	39.5	32.5	36.9
C25	Pancreas	917	22.9	15.7	12.5	23.8	17.4	14.6	13.2	15.2
C32	Larynx	1880	59.9	37.2	28.6	62.3	41.8	34.6	32.8	36.0
C33-34	Lung	3451	28.4	15.4	10.9	29.6	17.3	13.2	10.9	13.4
C50	Breast	7294	77.9	56.6	46.0	79.7	60.4	51.4	48.2	51.6
C53	Cervix	4436	75.2	53.6	42.2	76.6	56.6	46.1	43.8	46.4
C56	Ovary	2029	49.7	29.1	22.8	50.7	30.7	24.6	21.0	22.9
C60	Penis	327	75.1	49.2	43.6	77.9	54.9	51.6	47.1	53.3
C61	Prostate	1463	64.3	39.3	24.0	69.6	50.2	35.9	28.4	42.3
C62	Testis	383	69.3	58.0	53.0	70.0	59.5	55.2	55.1	56.2
C64	Kidney	819	53.0	38.2	31.2	54.8	41.8	36.0	32.1	35.2
C67	Urinary bladder	1307	67.0	45.6	32.5	70.6	53.6	41.8	34.6	45.6
C81	Hodgkin lymphoma	528	70.0	58.5	48.8	71.0	60.8	51.7	50.6	52.2
C82-85+C96	Non-Hodgkin lymphoma	2338	50.3	38.0	30.2	51.8	41.1	34.1	34.2	37.1
C91	Lymphoid leukaemia	1099	34.8	22.0	15.2	35.4	22.9	16.3	14.8	15.5
C92-94	Myeloid leukaemia	1261	31.2	20.6	13.7	31.8	21.5	14.6	12.8	15.2
C95	Leukaemia unspecified	345	18.7	10.3	6.1	19.2	10.9	6.7	5.9	7.1

Graphs:

1-, 3- and 5-year absolute survival (%)

1-, 3- and 5-year relative survival (%)

ASRS (%) all ages

ASRS (%) 0-74 years

Other tables available for this registry:

- Table1:	Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site (Mumbai, India, 1992-1994 cases followed through 1999 and 1995-1999 cases followed-up until 2003)
- Table2a:	Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site (Mumbai, India, 1992-1994 cases followed through 1999 and 1995-1999 cases followed-up until 2003)
- Table3:	Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site (Mumbai, India, 1992-1994 cases followed through 1999 and 1995-1999 cases followed-up until 2003)
- Table4:	Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group (Mumbai, India, 1992-1994 cases followed through 1999 and 1995-1999 cases followed-up until 2003)
- Table5b:	Proportion (%) of cases and 5-year absolute survival by extent of disease and site (Mumbai, India, 1992-1999)
- Table6:	Comparison of 5-year absolute and relative survival of cases diagnosed between 1982-1986 and 1992-1999 (Mumbai, India)

Registry chapter:

Consult the chapter in Cancer survival in developping countries (Volume II)